HomeACXP • NASDAQ
Acurx Pharmaceuticals Inc
add
$0.35
2.11%
After Hours:(1.29%)-0.0045
$0.34
Closed: Jun 5, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.15M | -50.91% |
Net income | -2.15M | 50.91% |
Net profit margin | — | — |
Earnings per share | -0.11 | 60.71% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.64M | -47.94% |
Total assets | 4.81M | -47.24% |
Total liabilities | 2.49M | -19.81% |
Total equity | 2.31M | — |
Shares outstanding | 23.48M | — |
Price to book | 3.55 | — |
Return on assets | -124.04% | — |
Return on capital | -367.19% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.15M | 50.91% |
Cash from operations | -2.05M | 33.02% |
Cash from investing | — | — |
Cash from financing | 2.99M | -33.73% |
Net change in cash | 937.17K | -35.22% |
Free cash flow | -1.69M | 11.78% |
Previous close
$0.36
Day range
$0.35 - $0.36
Year range
$0.30 - $3.33
Market cap
8.10M USD
Avg Volume
188.66K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
CEO
Founded
2017
Website
Employees
4
